Vascular Biogenics Price Prediction
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Oversold Vs Overbought
69
Oversold | Overbought |
Using Vascular Biogenics hype-based prediction, you can estimate the value of Vascular Biogenics from the perspective of Vascular Biogenics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vascular Biogenics to buy its stock at a price that has no basis in reality. In that case, they are not buying Vascular because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vascular Biogenics after-hype prediction price | USD 0.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vascular |
Vascular Biogenics After-Hype Price Prediction Density Analysis
As far as predicting the price of Vascular Biogenics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vascular Biogenics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vascular Biogenics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vascular Biogenics Estimiated After-Hype Price Volatility
In the context of predicting Vascular Biogenics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vascular Biogenics' historical news coverage. Vascular Biogenics' after-hype downside and upside margins for the prediction period are 0.28 and 0.28, respectively. We have considered Vascular Biogenics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vascular Biogenics is very steady at this time. Analysis and calculation of next after-hype price of Vascular Biogenics is based on 3 months time horizon.
Vascular Biogenics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vascular Biogenics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vascular Biogenics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vascular Biogenics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 12 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.28 | 0.28 | 0.00 |
|
Vascular Biogenics Hype Timeline
Vascular Biogenics is at this time traded for 0.28. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Vascular is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Vascular Biogenics is about 0.0%, with the expected price after the next announcement by competition of 0.28. About 13.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.35. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vascular Biogenics recorded a loss per share of 0.18. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 3 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.Vascular Biogenics Related Hype Analysis
Having access to credible news sources related to Vascular Biogenics' direct competition is more important than ever and may enhance your ability to predict Vascular Biogenics' future price movements. Getting to know how Vascular Biogenics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vascular Biogenics may potentially react to the hype associated with one of its peers.
Vascular Biogenics Additional Predictive Modules
Most predictive techniques to examine Vascular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vascular using various technical indicators. When you analyze Vascular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vascular Biogenics Predictive Indicators
The successful prediction of Vascular Biogenics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vascular Biogenics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vascular Biogenics based on analysis of Vascular Biogenics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vascular Biogenics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vascular Biogenics's related companies.
Story Coverage note for Vascular Biogenics
The number of cover stories for Vascular Biogenics depends on current market conditions and Vascular Biogenics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vascular Biogenics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vascular Biogenics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vascular Biogenics Short Properties
Vascular Biogenics' future price predictability will typically decrease when Vascular Biogenics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vascular Biogenics often depends not only on the future outlook of the potential Vascular Biogenics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vascular Biogenics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 77.6 M | |
| Cash And Short Term Investments | 20.7 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |